| 11613750 |
Methods of reducing virus molecule levels |
Chia-Cheng Kao, Leonid Beigelman |
2023-03-28 |
$891,000 |
| 11590155 |
Substituted nucleosides, nucleotides and analogs thereof |
Leonid Beigelman, Natalia Dyatkina, Julian Alexander Symons, David Bernard Smith |
2023-02-28 |
$178,787,000 |
| 11166976 |
S-antigen transport inhibiting oligonucleotide polymers and methods |
Leonid Beigelman, Rajendra K. Pandey, Vivek Kumar Rajwanshi, David Bernard Smith, Jin Hong |
2021-11-09 |
$14,576,000 |
| 10780105 |
Substituted nucleosides, nucleotides and analogs thereof |
Leonid Beigelman, Natalia Dyatkina, Julian Alexander Symons, David Bernard Smith |
2020-09-22 |
|
| 10307439 |
Substituted nucleosides, nucleotides and analogs thereof |
Leonid Beigelman, Julian Alexander Symons, David Bernard Smith |
2019-06-04 |
|
| 10052342 |
Substituted nucleosides, nucleotides and analogs thereof |
Leonid Beigelman, Natalia Dyatkina, Julian Alexander Symons, David Bernard Smith |
2018-08-21 |
|
| 10010536 |
Method of modulating stress-activated protein kinase system |
Scott D. Seiwert, Leonid Beigelman, Ramachandran Radhakrishnan, Karl Kossen, Vladimir Serebryany |
2018-07-03 |
|
| 9603863 |
Substituted nucleosides, nucleotides and analogs thereof |
Leonid Beigelman, Natalia Dyatkina, Julian Alexander Symons, David Bernard Smith |
2017-03-28 |
|
| 9603864 |
Substituted nucleosides, nucleotides and analogs thereof |
Leonid Beigelman, Julian Alexander Symons, David Bernard Smith |
2017-03-28 |
|
| 9527816 |
Method of modulating stress-activated protein kinase system |
Scott D. Seiwert, Leonid Beigelman, Ramachandran Radhakrishnan, Karl Kossen, Vladimir Serebryany |
2016-12-27 |
|
| 9504705 |
Hepatitis C viral infection treatment using a combination of compounds |
Julie Krop, Margaret James Koziel, John Fry, Sushmita Mukherjee Chanda |
2016-11-29 |
|
| 9012427 |
Pharmaceutical combinations comprising a thionucleotide analog |
Leonid Beigelman, Hua Tan, Julian Alexander Symons, David Bernard Smith, Min Jiang +2 more |
2015-04-21 |
|
| 8741936 |
Method of modulating stress-activated protein kinase system |
Scott D. Seiwert, Leonid Beigelman, Ramachandran Radhakrishnan, Karl Kossen, Vladimir Serebryany |
2014-06-03 |
$169,145,000 |
| 8299021 |
Macrocyclic inhibitors of hepatitis C virus replication |
Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher, Bradley Barnett +10 more |
2012-10-30 |
|
| 8119592 |
Compounds and methods for inhibiting hepatitis C viral replication |
Leonid Beigelman, Scott D. Seiwert, Steven W. Andrews, Julia Haas |
2012-02-21 |
$13,755,000 |
| 7932267 |
Use of α-glucosidase inhibitors to treat alphavirus infections |
Hua Tan, Scott D. Seiwert |
2011-04-26 |
$109,576,000 |
| 7932277 |
Peptide inhibitors of hepatitis C virus replication |
Scott D. Seiwert, Steven W. Andrews, Leonid Beigelman, Brad O. Buckman, Kevin Ronald Condroski +6 more |
2011-04-26 |
|
| 7829665 |
Macrocyclic inhibitors of hepatitis C virus replication |
Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher, Bradley Barnett +10 more |
2010-11-09 |
$24,983,000 |
| 7781474 |
Inhibitors of hepatitis C virus replication |
Scott D. Seiwert, Leonid Beigelman, Timothy Kercher, April L. Kennedy, Steven W. Andrews |
2010-08-24 |
$18,638,000 |
| 7728013 |
Method of modulating stress-activated protein kinase system |
Scott D. Seiwert, Leonid Beigelman, Ramachandran Radhakrishnan, Karl Kossen, Vladimir Serebryany |
2010-06-01 |
$16,101,000 |
| 7638488 |
Use of alpha-glucosidase inhibitors to treat alphavirus infections |
Hua Tan, Scott D. Seiwert |
2009-12-29 |
$9,115,000 |
| 7597884 |
Hyperglycosylated polypeptide variants and methods of use |
Scott D. Seiwert, Jin Hong |
2009-10-06 |
|
| 7491794 |
Macrocyclic compounds as inhibitors of viral replication |
Steven W. Andrews, Kevin Ronald Condroski, Yutong Jiang, April L. Kennedy, Peter J. Stengel +1 more |
2009-02-17 |
$11,527,000 |
| 7407973 |
Use of pirfenidone in therapeutic regimens |
Osman N. Ozes, Scott D. Seiwert |
2008-08-05 |
$9,325,000 |
| 5831062 |
Use of the human interferon consensus gene for gene therapy |
Milton W. Taylor |
1998-11-03 |
$51,811,000 |
